MTOR and hepatocellular carcinoma: The proliferation class accounts of 50% of all HCC, is HBV associated, with aberrations in TP53, RAS, mTOR, insulin-like growth factor (IGF), FGF19, and cyclin D1 (CCND1), and overall worse prognosis.